ATE185147T1 - Peptidliganden für die konstante region von immunoglobulinen - Google Patents

Peptidliganden für die konstante region von immunoglobulinen

Info

Publication number
ATE185147T1
ATE185147T1 AT96201706T AT96201706T ATE185147T1 AT E185147 T1 ATE185147 T1 AT E185147T1 AT 96201706 T AT96201706 T AT 96201706T AT 96201706 T AT96201706 T AT 96201706T AT E185147 T1 ATE185147 T1 AT E185147T1
Authority
AT
Austria
Prior art keywords
immunoglobulins
amino acid
constant region
peptide
peptide ligands
Prior art date
Application number
AT96201706T
Other languages
English (en)
Inventor
Giorgio Fassina
Antonio Verdoliva
Menotti Ruvo
Original Assignee
Tecnogen Scpa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IT95MI001328A external-priority patent/IT1276761B1/it
Priority claimed from IT96MI000831 external-priority patent/IT1282380B1/it
Application filed by Tecnogen Scpa filed Critical Tecnogen Scpa
Application granted granted Critical
Publication of ATE185147T1 publication Critical patent/ATE185147T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0815—Tripeptides with the first amino acid being basic
    • C07K5/0817—Tripeptides with the first amino acid being basic the first amino acid being Arg
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0812—Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02—Linear peptides containing at least one abnormal peptide link
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/537—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody
    • G01N33/538—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody by sorbent column, particles or resin strip, i.e. sorbent materials
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT96201706T 1995-06-21 1996-06-19 Peptidliganden für die konstante region von immunoglobulinen ATE185147T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT95MI001328A IT1276761B1 (it) 1995-06-21 1995-06-21 Peptidi multimerici
IT96MI000831 IT1282380B1 (it) 1996-04-29 1996-04-29 Peptide utile come ligando

Publications (1)

Publication Number Publication Date
ATE185147T1 true ATE185147T1 (de) 1999-10-15

Family

ID=26331293

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96201706T ATE185147T1 (de) 1995-06-21 1996-06-19 Peptidliganden für die konstante region von immunoglobulinen

Country Status (9)

Country Link
US (3) US5880259A (de)
EP (1) EP0752425B1 (de)
JP (1) JP3811524B2 (de)
CN (1) CN1183155C (de)
AT (1) ATE185147T1 (de)
CA (1) CA2179562C (de)
DE (1) DE69604454T2 (de)
DK (1) DK0752425T3 (de)
ES (1) ES2137620T3 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0752425B1 (de) 1995-06-21 1999-09-29 TECNOGEN Società Consortile per azioni Peptidliganden für die konstante Region von Immunoglobulinen
ITMI962628A1 (it) * 1996-12-16 1998-06-16 Tecnogen Scpa Composizione farmaceutica
CA2284619A1 (en) * 1997-03-25 1998-10-01 Kaneka Corporation Absorbent for eliminating hepatitis c virus, absorber, and absorption method
US6680376B2 (en) * 2000-12-08 2004-01-20 Good Biotech Corporation Process for selectively isolating avian immunoglobulins
US6957672B2 (en) * 2001-07-25 2005-10-25 Imperial Chemical Industries Plc Method for ensuring that coating compositions have correct color
US20050272917A1 (en) * 2004-05-14 2005-12-08 Hematech, Llc Methods for immunoglobulin purification
US7651647B1 (en) 2004-07-15 2010-01-26 Pacesetter, Inc. Method for producing highly conductive battery electrodes
ITMI20041569A1 (it) 2004-07-30 2004-10-30 Tecnogen Scpa "ligandi peptidici specifici per le immunoglobuline"
US7408030B2 (en) * 2005-01-13 2008-08-05 North Carolina State University Purification of immunoglobulins using affinity chromatography and peptide ligands
ITMI20071119A1 (it) 2007-06-01 2008-12-02 Tecnogen Spa Nuovi ligandi sintetici per immunoglobuline e composizioni farmaceutiche che li comprendono
MX374731B (es) 2016-06-06 2025-03-06 Univ Wien Med Método para la detección de un anticuerpo igm específico para un flavivirus en una muestra.
CN106279715A (zh) * 2016-08-30 2017-01-04 武汉大学 一种铜‑肽多孔配位聚合物及其制备方法和应用
CN114585434A (zh) * 2019-10-23 2022-06-03 新加坡国立大学 用于合成化合物的方法和系统

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5229490A (en) * 1987-05-06 1993-07-20 The Rockefeller University Multiple antigen peptide system
US5141862A (en) * 1990-04-17 1992-08-25 Smithkline Beecham Corporation Method of purifying tpa or plasminogen activator using a tripeptide of the formula: -X-Y-argininal wherein X and Y are selected from the group consisting of pro,phe,trp and tyr
US5227297A (en) * 1990-04-17 1993-07-13 Smithkline Beecham Corporation Affinity purification ligands
ATE200107T1 (de) * 1990-10-15 2001-04-15 Tecnogen Scpa Verfahren zur feststellung von proteolitischen wirkungen und/oder deren inhibitoren
GB9107434D0 (en) * 1991-04-09 1991-05-22 Medical Res Council Peptide-based assay
JPH07188283A (ja) * 1991-04-19 1995-07-25 Suetsuna Yoko 新規なトリペプチドおよびアンジオテンシン変換酵素 阻害剤
US5216126A (en) * 1991-06-19 1993-06-01 Genentech, Inc. Receptor polypeptides and their production and uses
JPH07508400A (ja) * 1992-03-03 1995-09-21 ザ　ソーク　インスティチュート　フォア　バイオロジカル　スタディーズ 受容体のインターナライゼーション・シグナル
WO1995006125A1 (en) * 1993-08-23 1995-03-02 Applied Immune Sciences, Inc. CHIMERIC RECEPTOR CONTAINING ONE IgG BINDING DOMAIN OF BOTH PROTEIN A AND PROTEIN G
EP0752425B1 (de) 1995-06-21 1999-09-29 TECNOGEN Società Consortile per azioni Peptidliganden für die konstante Region von Immunoglobulinen

Also Published As

Publication number Publication date
US6207807B1 (en) 2001-03-27
EP0752425A2 (de) 1997-01-08
CN1145369A (zh) 1997-03-19
ES2137620T3 (es) 1999-12-16
DK0752425T3 (da) 2000-04-10
CA2179562A1 (en) 1996-12-22
US5880259A (en) 1999-03-09
US6566077B1 (en) 2003-05-20
JPH0920795A (ja) 1997-01-21
DE69604454T2 (de) 2000-03-02
EP0752425B1 (de) 1999-09-29
EP0752425A3 (de) 1997-07-09
JP3811524B2 (ja) 2006-08-23
DE69604454D1 (de) 1999-11-04
CN1183155C (zh) 2005-01-05
CA2179562C (en) 2007-12-18

Similar Documents

Publication Publication Date Title
DE69604454D1 (de) Peptidliganden für die konstante Region von Immunoglobulinen
MY137301A (en) Peptide analogs as irreversible interleukin-1b protease inhibitors
EP0810209A3 (de) Hydroxyethylaminosulfonamide verwendbar als Inhibitoren retroviraler Proteasen
PT99677A (pt) Processo de preparacao de um polipeptido que se liga a gpiia-iiib de vectores de composicoes de anticorpos e processo de ligacao de celulas a um substrato
DE69408666D1 (de) Risperidon pamoate
CA2011294A1 (en) Carbonylation catalyst system
ES2176456T3 (es) Procedimiento de preparacion de un compuesto inhibidor del vih proteasa.
BR8700951A (pt) Composicoes catalisadoras,processo para a preparacao de copolimeros,copolimeros e terpolimeros
IL116401A0 (en) Amid s of ono a d dic rboxy ic acids with aminoalcohols selectively active on the cannabinoid peripheral receptor
DE3372289D1 (en) Peptide derivatives as inhibitors of acid proteases
TR200001740T2 (tr) Mikrobisidal ve bitkiye bağışıklık kazandırıcı aktiviteleri olan tiyazol-türevleri
CA2010035A1 (en) Proline derivatives
BR9101963A (pt) Processo para preparar um composto terminado em amina
ATE144493T1 (de) Verfahren und herstellung von salicylaldoxim- derivaten
DE69429224D1 (de) Zwischenprodukte für die Synthese von Cephalosporinen
CA2032303A1 (en) Inhibitors of retroviral proteases
CA1264899C (en) SYNTHESIS OF PEPTIDES USING THIOXANTHYLMETHYLOXYCARBONYL DIOXIDES
ATE180679T1 (de) Neue verbesserungen hinsichtlich der radiomarkierung von proteinen
BR9406352A (pt) Processo para a fabricição de ácido aminometanofosfonico
KR860000268A (ko) N-벤조일-n'-피리미디닐옥시페닐 우레아 화합물류의 제조방법
ES8206506A1 (es) Procedimiento de preparacion de amino alcosi furanos o tio- fenos.
ATE80381T1 (de) Verfahren zur herstellung von n,n'-bis(3aminophenyl)harnstoffen.
ATE224724T1 (de) Pharmazeutische zusammensetzung enthaltend peptide für die inhibierung der immunoglobulin- rezeptor interaktion
KR940003929A (ko) N, n, n'-삼치환된 우레아의 분해에 의한 이소시아네이트의 제조방법
MX173930B (es) Procedimiento para preparar compuestos de 1h-benzotriazol-hidroxietil -sulfona n1 sustituidos y su empleo para la preparacion de colorantes

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee